Mira Dx
About:
Mira Dx is a genomics company dedicated to the development and commercialization of novel microRNA-based diagnostic tests.
Website: http://www.miradx.com
Twitter/X: MIRADX1
Top Investors: Connecticut Innovations
Description:
Mira Dx is a genomics company dedicated to the development and commercialization of novel microRNA-based diagnostic tests. The company's goal is to help clinicians better understand cancer and enhance decision making.
Total Funding Amount:
$4M
Estimated Revenue Range:
$10M to $50M
Headquarters Location:
New Haven, Connecticut, United States
Founded Date:
2008-01-01
Contact Email:
info(AT)miradx.com
Founders:
Frank Slack, Joanne Weidhaas
Number of Employees:
1-10
Last Funding Date:
2010-07-01
IPO Status:
Private
Industries:
© 2025 bioDAO.ai